GCTK:NASDAQ, GlucoTrack, Inc.
GCTK stock overview
GlucoTrack, Inc. (GCTK:NASDAQ) closed at $1.61 on October 26, 2026,
up 95.67% on the day.
The stock trades 99.3% below its 52-week high of $225.00
and 115.8% above its 52-week low of $0.746.
Over the past year, it lost 75.8%.
GlucoTrack, Inc. is part of the Health Care sector.
Key figures
- Price
- $1.61
- Day change
- +95.67%
- Volume
- 33,741,955
- Average volume
- 1,478,399
- Market cap
- 1M+
- 52-week range
- $0.746 – $225.00
- 50-day average
- $4.94
- 200-day average
- $25.55
Price action over the past year
In 251 trading sessions since October 24, 2025, GCTK closed higher on 91 days (36%).
Its best day was October 26, 2026 (+299.50%) and its worst was July 31, 2026 (-38.85%).
The stock moved 10% or more in a single session 48 times.
It opened at least 5% above the previous day's high 8 times.
Recent signals
GCTK news
-
Oct 22, 2026:
Glucotrack, Inc. Announces Reverse Stock Split
-
Oct 14, 2026:
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
-
Oct 14, 2026:
Qare Is Here: Lokahi Therapeutics Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
-
Oct 1, 2026:
Lkahi Therapeutics Expands University of Georgia Collaboration Through First International ai Pipeline Project with Universitt Paderborn
-
Oct 1, 2026:
Lokahi Therapeutics Expands University of Georgia Collaboration Through First International ai² Pipeline Project with Universitat Paderborn
-
Oct 1, 2026:
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
-
Sep 30, 2026:
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
-
Sep 30, 2026:
Lokahi Therapeutics Announces Qare, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
About GlucoTrack, Inc.
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
Similar stocks
Find more stocks like GCTK with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.